Annovis Bio ANVS Edges Higher as Stock Tests Key Resistance at 202 Novartis Upgrades FullYear Outlook Sales and Profit Guidance Raised ALTG Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower American College Students AI Reluctance Raises Questions for EdTech Sector